Cellular therapy gives hope to cancer patients

31 July 2019 | Research

Prof Dario Campana from the Dept of Paediatrics at NUS Yong Loo Lin School of Medicine developed the CAR-T cell immunotherapy, which involves drawing immune cells from a patient's blood and equipping each with a Chimeric Antigen Receptor (CAR) - a receptor which binds itself to a specific protein on the cancer cells. This enables the immune cells to track down cancer cells and kill them.